专利信息

首页 1 2 3 4 5 6 下页尾页共 492 条记录, 当前第1/50页。

专利标题：Process for the preparation of orlistat

The present invention provides a process for preparing orlistat from amino orlistat using Pivaloyl Formic Anhydride (PFA) as an alkanoylating agent.

专利标题：Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes

专利权人：F. Hoffmann-la Roche Ag;

Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin or orlistat for the manufacture of oral medicaments for treating or preventing type II diabetes mellitus and the medicaments thus manufactured. The tetrahydrolipstatin is employed in unit dosage form formulated in an oral composition and in the range of from 60 to 720 mg of tetrahydrolipstatin per day.

专利标题：A kind of crystallization and purification method of orlistat

专利标题：Pharmaceutical composition having antidiabetic and antiobesity activities

专利权人：Cgk Bio Inc.;

The present invention provides a pharmaceutical composition for preventing and treating diabetes or a pharmaceutical composition for preventing and treating obesity. The pharmaceutical composition for preventing and treating diabetes according to the present invention has the effect of significantly reducing blood sugar and also exhibits antidiabetic effects that are almost equal to those of metfornin which has been mostly used as a therapeutic agent for type 2 diabetes. The pharmaceutical compo...

专利标题：A kind of orlistat oral solid formulation and preparation method thereof

专利标题：Prevention and treatment of obesity and metabolic diseases induced by obesity using microorganisms

专利权人：Jinis Biopharmaceuticals Co.;

专利标题：Method for purifying orlistat intermediate

专利标题：Chinese and western compound weight reducing medicine composition and preparation method thereof

专利标题：Pharmaceutical compositions comprising orlistat

专利权人：KRKA;

The present invention pertains to pharmaceutical compositions comprising orlistat as active ingredient. In particular the present invention relates to such pharmaceutical compositions having an improved stability with respect to environmental conditions such as increased temperature and moisture.

专利标题：New pharmaceutical composition

专利权人：F. Hoffmann-la Roche Ag;

A pharmaceutical combination or composition containing a lipase inhibitor preferably orlistat and a bile acid sequestrant is useful for treating obesity.

当前查询条件: [药品] 包含 'Orlistat'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. US8680298B2	2014/3/25	US12/602947	2008/6/6
专利标题：Process for the preparation of orlistat 专利权人：RANBAXY LABORATORIES LIMITED; The present invention provides a process for preparing orlistat from amino orlistat using Pivaloyl Formic Anhydride (PFA) as an alkanoylating agent.

2. CA2278854C	2014/3/4	CA19982278854	1998/1/29
专利标题：Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin for treating type ii diabetes 专利权人：F. Hoffmann-la Roche Ag; Use of the gastrointestinal lipase inhibitor tetrahydrolipstatin or orlistat for the manufacture of oral medicaments for treating or preventing type II diabetes mellitus and the medicaments thus manufactured. The tetrahydrolipstatin is employed in unit dosage form formulated in an oral composition and in the range of from 60 to 720 mg of tetrahydrolipstatin per day.

3. CN103588735A	2014/2/19	CN20131562209	2013/11/13
专利标题：A kind of crystallization and purification method of orlistat 专利权人：

4. WO2014017787A1	2014/1/30	WO2013KR06524	2013/7/22
专利标题：Pharmaceutical composition having antidiabetic and antiobesity activities 专利权人：Cgk Bio Inc.; The present invention provides a pharmaceutical composition for preventing and treating diabetes or a pharmaceutical composition for preventing and treating obesity. The pharmaceutical composition for preventing and treating diabetes according to the present invention has the effect of significantly reducing blood sugar and also exhibits antidiabetic effects that are almost equal to those of metfornin which has been mostly used as a therapeutic agent for type 2 diabetes. The pharmaceutical compo...

5. CN103505453A	2014/1/15	CN20121214093	2012/6/27
专利标题：A kind of orlistat oral solid formulation and preparation method thereof 专利权人：

6. CN102438638B	2013/12/18	CN20098159183	2009/6/5
专利标题：Prevention and treatment of obesity and metabolic diseases induced by obesity using microorganisms 专利权人：Jinis Biopharmaceuticals Co.;

7. CN103420953A	2013/12/4	CN20131310092	2013/7/19
专利标题：Method for purifying orlistat intermediate 专利权人：Hangzhou Huadong Medicine Group Biology Engineering Research Co., Ltd;

8. CN103394044A	2013/11/20	CN20131368511	2013/8/21
专利标题：Chinese and western compound weight reducing medicine composition and preparation method thereof 专利权人：Guangzhou Medcan Pharmatech Ltd.;

9. SI2002825T1	2013/10/30	SI20070031294T	2007/6/14
专利标题：Pharmaceutical compositions comprising orlistat 专利权人：KRKA; The present invention pertains to pharmaceutical compositions comprising orlistat as active ingredient. In particular the present invention relates to such pharmaceutical compositions having an improved stability with respect to environmental conditions such as increased temperature and moisture.

10. HU229292B1	2013/10/28	HU20030001281	2001/7/19
专利标题：New pharmaceutical composition 专利权人：F. Hoffmann-la Roche Ag; A pharmaceutical combination or composition containing a lipase inhibitor preferably orlistat and a bile acid sequestrant is useful for treating obesity.

下载范围

下载内容